Vnitr Lek 2019, 65(11):715-720 | DOI: 10.36290/vnl.2019.124

Pancytopenia, panhypopituitarism and liver cirrhosis: analysis of a difficult clinical case

Pavel Polák1,2,*, Jan Kamelander1, Jana Michalcová1,2, Jiřina Zavřelová1,3, Libor Červinek4, Tomáš Rohan5, Zuzana Pazdičová5, Václav Odstrčilík6, Miroslav Penka1,2,3
1 Oddělení klinické hematologie FN Brno, pracoviště Bohunice
2 LF MU, Brno
3 Katedra laboratorních metod LF MU, Brno
4 Interní hematologická a onkologická klinika LF MU a FN Brno, pracoviště Bohunice
5 Klinika radiologie a nukleární medicíny LF MU a FN Brno, pracoviště Bohunice
6 Klinika ústní, čelistní a obličejové chirurgie LF MU a FN Brno, pracoviště Bohunice

Panhypopituitarism following craniopharyngioma resection has systemic impact with potential influence on physiological hematopoiesis. There is a growing body of evidence of liver fibrosis/cirrhosis risk development due to altered metabolism and lipid accumulation. The authors present a case report of a woman with a history of craniopharyngioma resection followed by aggravating pancytopenia with suspected indolent lymphoproliferative disorder and possible acquired bone marrow aplasia syndrome due to paroxysmal nocturnal hemoglobinuria. A complex hemostasis disorder with deficiency of multiple coagulation factors (FXII, FXI, FX, FIX, FVII, FX, FV, FXIII, antitrombin, protein C, protein S) was accidentally detected. Despite normal sonographic liver imaging, all possible causes of chronic liver disease were systematically excluded (viral hepatitis, hemochromatosis, Wilson's disease, α-1-antitrypsin deficiency); anti-LKM-1 and anti-ENA antibodies were detected. Finally, the magnetic resonance imaging confirmed image of liver cirrhosis - with signs of portal hypertension.

Keywords: coagulopathy; liver cirrhosis; pancytopenia; panhypopituitarism

Received: May 22, 2019; Accepted: September 9, 2019; Published: November 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Polák P, Kamelander J, Michalcová J, Zavřelová J, Červinek L, Rohan T, et al.. Pancytopenia, panhypopituitarism and liver cirrhosis: analysis of a difficult clinical case. Vnitr Lek. 2019;65(11):715-720. doi: 10.36290/vnl.2019.124.
Download citation

References

  1. Kim DY, Kim JH, Park YJ et al. Case of complete recovery of pancytopenia after treatment of hypopituitarism. Ann Hematol 2004; 83(5): 309-312. Dostupné z DOI: <http://dx.doi.org/10.1007/s00277-003-0800-4>. Go to original source... Go to PubMed...
  2. Holmes GI, Shepherd P, Walker JD. Panhypopituitarism secondary to a macroprolactinoma manifesting with pancytopenia: case report and literature review. Endocr Pract 2011; 17(2): e32-e36. Dostupné z DOI: <http://dx.doi.org/10.4158/EP10298.CR>. Go to original source... Go to PubMed...
  3. Lang D, Mead JS, Sykes DB. Hormones and the bone marrow: panhypopituitarism and pancytopenia in a man with a pituitary adenoma. J Gen Intern Med 2015; 30(5): 692-696. Dostupné z DOI: <http://dx.doi.org/10.1007/s11606-014-3161-x>. Go to original source... Go to PubMed...
  4. Hüning I, Gillessen-Kaesbach G. Fibrodysplasia ossificans progressiva: clinical course, genetic mutations and genotype-phenotype correlation. Mol Syndromol 2014; 5(5): 201-211. Dostupné z DOI: <http://dx.doi.org/10.1159/000365770>. Go to original source... Go to PubMed...
  5. Licata MJ, Janakiram M, Tan S et al. Diagnostic challenges of adult T-cell leukemia/lymphoma in North America - a clinical, histological, and immunophenotypic correlation with a workflow proposal. Leuk Lymphoma 2018; 59(5): 1188-1194. Dostupné z DOI: <http://dx.doi.org/10.1080/10428194.2017.1365862>. Go to original source... Go to PubMed...
  6. Sahin F, Ozkan MC, Mete NG et al. Multidisciplinary clinical management of paroxysmal nocturnal hemoglobinuria. Am J Blood Res 2015; 5(1): 1-9. Go to original source... Go to PubMed...
  7. Boyer T, Grardel N, Copin MC et al. Paroxysmal nocturnal hemoglobinuria (PNH) and T cell large granular lymphocyte (LGL) leukemia - an unusual association: another cause of cytopenia in PNH. Ann Hematol 2015; 94(10): 1759-1760. Dostupné z DOI: <http://dx.doi.org/10.1007/s00277-015-2439-3>. Go to original source... Go to PubMed...
  8. Čermák J. Aplastická anémie. Vnitř Lék 2018; 64(5): 501-507. Go to original source... Go to PubMed...
  9. Orlandi E, Boselli P, Covezzi R et al. Reversal of bone marrow hypoplasia in anorexia nervosa: case report. Int J Eat Disord 2000; 27(4): 480-482. Go to original source...
  10. Greer JP, Arber DA, Blader B et al. Wintrobe's clinical hematology. 13th ed. Lippincott Williams and Wilkins: Philadelphia, USA 2014. ISBN 978-1451172683.
  11. Maier KP. Hepatitis - Hepatitisfolgen. 6th ed. Hans Huber: Bern 2010. ISBN 978-3456846743
  12. Alfani R, Vassallo E, De Anseris AG et al. Pediatric fatty liver and obesity: not always just a matter of non-alcoholic fatty liver disease. Children (Basel) 2018; 5(12). pii: E169. Dostupné z DOI: <http://dx.doi.org/10.3390/children5120169>. Go to original source... Go to PubMed...
  13. Jung SY, Lee YJ, Lee HJ et al. Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma. Ann Pediatr Endocrinol Metab 2017; 22(3): 189-196. Dostupné z DOI: <http://dx.doi.org/10.6065/apem.2017.22.3.189>. Go to original source... Go to PubMed...
  14. Liberal R, Grant CR, Longhi MS et al. Diagnostic criteria of autoimmune hepatitis. Autoimmun Rev 2014; 13(4-5): 435-440. Dostupné z DOI: <http://dx.doi.org/10.1016/j.autrev.2013.11.009>. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.